Equities researchers at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Trading Up 1.1 %
Shares of MDRX stock opened at $9.60 on Friday. The company has a 50 day moving average price of $9.49 and a 200-day moving average price of $9.23. Veradigm has a 52 week low of $5.01 and a 52 week high of $13.22.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Transportation Stocks Investing
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
